Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause

Department of Cardiology, Matsuyama Red Cross Hospital, Japan.

OBJECTIVES. This study was undertaken to assess myocardial adrenergic activity using iodine-123 metaiodobenzylguanidine (MIBG) imaging in patients with heart failure. BACKGROUND. In patients with congestive heart failure, adrenergic nerve activity is accelerated. However, whether myocardial adrenergic nerve activity reflects the severity of heart failure and its relation to the underlying cause have not yet been elucidated. METHODS. Planar MIBG images were obtained from 96 patients with heart failure and compared with images from 9 age-matched healthy subjects. Groups 1 and 2 included 65 patients with heart failure related to impaired myocardial function and whose left ventricular ejection fraction was < 40% (group 1 = 40 patients with dilated cardiomyopathy; group 2 = 25 patients with ischemic cardiomyopathy). Group 3 included 31 patients with heart failure related to a mechanical abnormality and whose left ventricular ejection fraction was > 40% (mitral regurgitation in 16, aortic regurgitation in 9, aortic and mitral regurgitation in 4, ruptured aneurysm of Valsalva in 2). Myocardial uptake of MIBG was calculated as the heart/mediastinal activity ratio. Storage and release of MIBG were calculated as percent myocardial MIBG washout from 15 min to 4 h after isotope injection. RESULTS. The heart/mediastinal activity ratio in the immediate images (15 min) showed a significant decrease only in patients with severe heart failure (groups 1 and 2). The myocardial washout was accelerated in all three heart failure groups. The level of myocardial washout was related to severity of heart failure and correlated well with New York Heart Association functional classification. CONCLUSIONS. In severe heart failure associated with cardiomyopathy, norepinephrine uptake is reduced. In addition, myocardial adrenergic nerve activity is accelerated in proportion to severity of heart failure, independent of the underlying cause.

This article has been cited by other articles:

				Y.-M. Cha, P. Chareonthaitawee, Y.-X. Dong, B. J. Kemp, J. K. Oh, C. Miyazaki, D. L. Hayes, R. F. Rea, S. J. Asirvatham, T. L. Webster, et al. Cardiac Sympathetic Reserve and Response to Cardiac Resynchronization Therapy Circ Heart Fail, May 1, 2011; 4(3): 339 - 344. [Abstract] [Full Text] [PDF]

				I. Matsunari, H. Aoki, Y. Nomura, N. Takeda, W.-P. Chen, J. Taki, K. Nakajima, S. G. Nekolla, S. Kinuya, and K. Kajinami Iodine-123 Metaiodobenzylguanidine Imaging and Carbon-11 Hydroxyephedrine Positron Emission Tomography Compared in Patients With Left Ventricular Dysfunction Circ Cardiovasc Imaging, September 1, 2010; 3(5): 595 - 603. [Abstract] [Full Text] [PDF]

				S. G. Drakos, T. Athanasoulis, K. G. Malliaras, J. V. Terrovitis, N. Diakos, D. Koudoumas, A. S. Ntalianis, S. P. Theodoropoulos, M. H. Yacoub, and J. N. Nanas Myocardial Sympathetic Innervation and Long-Term Left Ventricular Mechanical Unloading J. Am. Coll. Cardiol. Img., January 1, 2010; 3(1): 64 - 70. [Abstract] [Full Text] [PDF]

				H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart, October 1, 2007; 93(10): 1213 - 1218. [Abstract] [Full Text] [PDF]

				P. A. Gould, G. Kong, V. Kalff, S. J. Duffy, A. J. Taylor, M. J. Kelly, and D. M. Kaye Improvement in cardiac adrenergic function post biventricular pacing for heart failure Europace, September 1, 2007; 9(9): 751 - 756. [Abstract] [Full Text] [PDF]

				M. Mabuchi, M. Imamura, N. Kubo, K. Morita, K. Noriyasu, T. Tsukamoto, K. Yasuda, and N. Tamaki Sympathetic Denervation and Reinnervation After the Maze Procedure J. Nucl. Med., July 1, 2005; 46(7): 1089 - 1094. [Abstract] [Full Text] [PDF]

				E. Plante, D. Lachance, M. Gaudreau, M.-C. Drolet, E. Roussel, M. Arsenault, and J. Couet Effectiveness of {beta}-Blockade in Experimental Chronic Aortic Regurgitation Circulation, September 14, 2004; 110(11): 1477 - 1483. [Abstract] [Full Text] [PDF]

				G. Hiasa, M. Hamada, H. Saeki, A. Ogimoto, T. Ohtsuka, Y. Hara, and Y. Shigematsu Cardiac Sympathetic Nerve Activity Can Detect Congestive Heart Failure Sensitively in Patients With Hypertrophic Cardiomyopathy Chest, September 1, 2004; 126(3): 679 - 686. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, I. J. Kopin, and D. S. Goldstein Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine Pharmacol. Rev., September 1, 2004; 56(3): 331 - 349. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, T. Ishikawa, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity in Patients with Decompensated Congestive Heart Failure J. Nucl. Med., July 1, 2004; 45(7): 1108 - 1113. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 19, 2003; 41(4): 574 - 581. [Abstract] [Full Text] [PDF]

				T. Yamada, T. Shimonagata, M. Fukunami, K. Kumagai, H. Ogita, A. Hirata, M. Asai, N. Makino, H. Kioka, H. Kusuoka, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study J. Am. Coll. Cardiol., January 15, 2003; 41(2): 231 - 238. [Abstract] [Full Text] [PDF]

				K. Watanabe, T. Takahashi, M. Nakazawa, M. I. I. Wahed, K. Fuse, N. Tanabe, M. Kodama, Y. Aizawa, H. Ashino, and S. Tazawa Effects of Carvedilol on Cardiac Function and Cardiac Adrenergic Neuronal Damage in Rats with Dilated Cardiomyopathy J. Nucl. Med., April 1, 2002; 43(4): 531 - 535. [Abstract] [Full Text] [PDF]

				D. L. Jardine, C. J. Charles, I. C. Melton, C. N. May, M. D. Forrester, C. M. Frampton, S. I. Bennett, and H. Ikram Continual recordings of cardiac sympathetic nerve activity in conscious sheep Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H93 - H99. [Abstract] [Full Text] [PDF]

				H Ogita, T Shimonagata, M Fukunami, K Kumagai, T Yamada, Y Asano, A Hirata, M Asai, H Kusuoka, M Hori, et al. Prognostic significance of cardiac 123I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study Heart, December 1, 2001; 86(6): 656 - 660. [Abstract] [Full Text] [PDF]

				T. Wakabayashi, T. Nakata, A. Hashimoto, S. Yuda, K. Tsuchihashi, M. I. Travin, and K. Shimamoto Assessment of Underlying Etiology and Cardiac Sympathetic Innervation to Identify Patients at High Risk of Cardiac Death J. Nucl. Med., December 1, 2001; 42(12): 1757 - 1767. [Abstract] [Full Text] [PDF]

				A. Cohen-Solal, Y. Esanu, D. Logeart, F. Pessione, C. Dubois, G. Dreyfus, R. Gourgon, and P. Merlet Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis J. Am. Coll. Cardiol., March 1, 1999; 33(3): 759 - 766. [Abstract] [Full Text] [PDF]

				K. Sakata, M. Shirotani, H. Yoshida, and C. Kurata Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension J. Am. Coll. Cardiol., August 1, 1998; 32(2): 438 - 443. [Abstract] [Full Text] [PDF]